Novo Nordisk Stock Jumps After Earnings. Compounding Market’s Growth Took it By Surprise
Novo Nordisk Stock Jumps After Earnings. Compounding Market’s Growth Took it By Surprise · Barrons.com

In This Article:

The Danish drugmaker now expects sales growth between 13% and 21%, down from a previous range of 16% to 24%.